Trial Site Detail
Drug: |
Imatinib + Bevacizumab |
|||
|---|---|---|---|---|
Trial: |
Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Terminated |
|||
Tom Baker Cancer Center |
Principal Investigator: |
Vivien H.C. Bramwell, MB,PhD,FRCP |
|---|---|
Contact: |
403-521-3707 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Tom Baker Cancer Center Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.